查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1193067

颅内动脉瘤市场：按类型（手术夹闭、血管内弹簧圈、分流器等）按最终用户（医院、诊所、其他）分类：2021-2031 年全球机会分析和行业预测

Intracranial Aneurysm Market By Type (Surgical Clipping, Endovascular Coiling, Flow Diverters, Others), By End User (Hospitals, Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 243 Pages | 商品交期: 2-3个工作天内

价格

2021 年全球颅内动脉瘤市场价值 130189 万美元，2031 年达到 270979 万美元，2022 年至 2031 年的复合年增长率预计为 7.6%。

脑动脉或颅内动脉瘤是由于血管壁内肌层（内膜）弱化引起的大脑动脉异常局部扩张，这种扩张会导致脑动脉瘤。 血管会变得扩张、“水泡”状、变薄，并在没有警告的情况下破裂。 结果是出血到大脑周围的空间，称为蛛网膜下腔出血 (SAH)。 这种出血会导致中风、昏迷和死亡。

动脉瘤通常位于大脑底部，就在颅骨内部，在称为蛛网膜下腔的区域中。 事实上，90% 的蛛网膜下腔出血 (SAH) 是由脑动脉瘤破裂引起的。 然而，有多种因素被认为会导致脑动脉瘤的形成，包括高血压、吸烟、先天易感性、血管损伤/外伤以及某些类型的血液感染引起的并发症。

推动市场增长的主要因素包括脑血管病患者人数的增加和患有高血压的老年人口的快速增加。 例如，脑动脉瘤基金会发布的一份报告估计，美国有 650 万人患有未破裂的脑动脉瘤，即每 50 人中就有 1 人。 此外，每年的破裂率约为每 10 万人中有 8 至 10 人，美国每年约有 3 万人患有脑动脉瘤破裂。 此外，据报导，女性比男性更容易患脑动脉瘤（比例为3:2），尤其是55岁及以上的人患脑动脉瘤破裂的风险比男性高（约为男性的1.5倍）。 全世界每年有近 50 万人死于脑动脉瘤，其中一半年龄在 50 岁以下。 脑血管病是由于高血压、吸烟、不健康的生活方式等导致血管受损，导致脑动脉瘤。 此外，对微创手术的需求不断增加将推动市场增长，因为小切口可减少术后疼痛并促进快速恢復，从而导致这些手术在开颅手术中得到广泛采用。我会给你提振。 许多主要参与者不断投资于研发活动，以推出创新的微创血管内捲绕器械，这有望推动市场增长。

然而，治疗动脉瘤引起的蛛网膜下腔出血的高成本和手术过程中的高健康风险阻碍了市场增长。 另一方面，发展中国家和低收入国家的新兴医疗保健市场缺乏基本医疗保健，大流行病和高血压相关疾病的风险增加，预计将在预测期内为市场增长提供有利可图的机会。

内容

第一章介绍

第 2 章执行摘要

第 3 章市场概述

  • 市场定义和范围
  • 主要发现
    • 主要投资领域
  • 波特的五力分析
  • 主要公司的定位
  • 市场动态
    • 司机
    • 约束因素
    • 机会
  • COVID-19 影响分析

第 4 章颅内动脉瘤市场：按类型

  • 概览
    • 市场规模和预测
  • 手术剪报
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 血管内弹簧圈
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 分流器
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 其他
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类

第 5 章颅内动脉瘤市场：按最终用户分类

  • 概览
    • 市场规模和预测
  • 医院
    • 主要市场趋势、增长动力和机遇
    • 市场规模/预测：按地区
    • 市场分析：按国家/地区分类
  • 医务室
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 其他
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类

第 6 章颅内动脉瘤市场：按地区

  • 概览
    • 市场规模和预测
  • 北美
    • 主要趋势和机会
    • 北美市场规模和预测：按类型
    • 北美市场规模和预测：按最终用户分类
    • 北美市场规模和预测：按国家/地区分类
      • 美国
      • 加拿大
      • 墨西哥
  • 欧洲
    • 主要趋势和机会
    • 欧洲市场规模和预测：按类型
    • 欧洲市场规模和预测：按最终用户分类
    • 欧洲市场规模和预测：按国家/地区分类
      • 德国
      • 法国
      • 英国
      • 意大利
      • 西班牙
      • 其他欧洲
  • 亚太地区
    • 主要趋势和机会
    • 亚太市场规模和预测：按类型
    • 亚太市场规模和预测：按最终用户分类
    • 亚太地区的市场规模和预测：按国家/地区分类
      • 日本
      • 中国
      • 澳大利亚
      • 印度
      • 韩国
      • 其他亚太地区
  • 拉美
    • 主要趋势和机会
    • LAMEA 市场规模和预测：按类型
    • LAMEA 市场规模和预测：按最终用户分类
    • LAMEA 市场规模和预测：按国家/地区分类
      • 巴西
      • 沙特阿拉伯
      • 南非
      • LAMEA 的其余部分

第七章商业条件

  • 介绍
  • 关键成功策略
  • 10 家主要公司的产品映射
  • 比赛仪表板
  • 竞争热图
  • 主要发展

第八章公司简介

  • B. Braun
  • Delta Surgical
  • Evonos GmbH & Co. KG
  • Integra Life-science Holding Corporation
  • Medtronic PLC
  • Microport Scientific Corporation
  • Mizuho Medical Incorporation
  • Spiegelberg
  • Stryker Corporation
  • Terumo Global（Microvention）
Product Code: A10205

The global intracranial aneurysm market was valued at $1,301.89 million in 2021, and is projected to reach $2,709.79 million by 2031, registering a CAGR of 7.6% from 2022 to 2031.A cerebral or intracranial aneurysm is an abnormal focal dilation of an artery in the brain that results from weakening of the inner muscular layer (the intima) of a blood vessel wall. The vessel develops a "blister-like" dilation that can become thin and rupture without warning. This results in bleeding into the space around the brain, which is called a subarachnoid hemorrhage (SAH). This kind of hemorrhage can lead to a stroke, coma, and/or death.

Aneurysms are usually found at the base of brain, just inside the skull, in an area called subarachnoid space. In fact, ruptured cerebral aneurysms are responsible for 90% of subarachnoid hemorrhage (SAH). However, a number of factors are believed to contribute in formation of cerebral aneurysms, including hypertension, smoking, congenital predisposition, injury, or trauma to blood vessels and complications from some types of blood infections.

Key factors that drive growth of the market include rise in number of patients suffering from cerebrovascular disease and surge in geriatric population suffering from hypertension. For instance, according to a report published by the Brain Aneurysm Foundation, it has been estimated that 6.5 million people in the U.S. have an unruptured brain aneurysm i.e., 1 in 50 people. The annual rate of rupture is approximately 8-10 per 100,000 people and around 30,000 people in the U.S. suffer a brain aneurysm rupture each year. Moreover, it has been reported that women are more likely than men to have a brain aneurysm (3:2 ratio), particularly those over the age of 55 have a higher risk of brain aneurysm rupture than men (about 1.5 times the risk). There are almost 500,000 deaths worldwide each year caused by brain aneurysms, and half the victims are younger than 50. The reason behind rise in prevalence of cerebrovascular disease are hypertension, cigarette smoking, and unhealthy lifestyle which leads to injury or trauma to blood vessels causing brain aneurysm. Furthermore, rise in the demand for minimally invasive surgeries, as smaller incisions decrease postoperative pain and facilitate speedy recovery leading to high adoption of these procedures for craniotomy surgery boost the market growth. Numerous key players are continuously investing in R&D activities for the launch of innovative minimally invasive endovascular coiling instruments are anticipated to fuel the market growth.

However, high management cost of aneurysm subarachnoid hemorrhage and high health risk during surgeries hamper the market growth. Conversely, emerging healthcare markets in developing countries and low-income countries lacking access to basic healthcare and increase in risk of pandemic and hypertension related disorders is expected to provide the lucrative opportunity for the growth of market during the forecast period. 

The intracranial aneurysm market is segmented on the basis of type, end user, and region. By type the market is segmented into surgical clipping, endovascular coiling, flow diverters, and others. By end user, it segmented into hospitals, clinics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

North America accounted for a majority of the intracranial aneurysm market share in 2021, and is anticipated to remain dominant during the forecast period, owing to the presence of well-established healthcare facilities, a growing geriatric population, and a high incidence of hypertension and stroke. Moreover, increase in prevalence of intracranial aneurysms and rise in demand for minimally invasive procedures contribute toward the market growth in the region. Furthermore, increase in number of initiatives undertaken by various organizations to spread awareness and reduce number of deaths due to cerebral aneurysms through innovative research is expected to fuel the market growth.

Asia-Pacific is expected to register fastest CAGR during the forecast period. This is attributed to presence of high unmet medical needs and constantly improving healthcare infrastructure. In addition, rapidly growing geriatric population, lifestyle stress, rise in incidences of hypertension, large population, improvement in quality of diagnosis, and increase in patient affordability are expected to drive the market in Asia-Pacific. This helps several market players to invest in Asia-Pacific countries, which further contributes toward growth of the market.

Key players that operate in the Intracranial aneurysm market are B. Braun, Delta Surgical, Evonos GmbH & Co. KG, Integra Lifescience Holding Corporation, Medtronic PLC, Microport Scientific Corporation, Mizuho Medical Incorporation, Spiegelberg, Stryker Corporation, and Terumo Global (Microvention).

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the intracranial aneurysm market analysis from 2021 to 2031 to identify the prevailing intracranial aneurysm market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the intracranial aneurysm market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global intracranial aneurysm market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Surgical Clipping
  • Endovascular Coiling
  • Flow Diverters
  • Others

By End User

  • Hospitals
  • Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Rest of Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • B. Braun
    • Delta Surgical
    • Evonos GmbH & Co. KG
    • Integra Life-science Holding Corporation
    • Medtronic PLC
    • Microport Scientific Corporation
    • Mizuho Medical Incorporation
    • Spiegelberg
    • Stryker Corporation
    • Terumo Global (Microvention)

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: INTRACRANIAL ANEURYSM MARKET, BY TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Surgical Clipping
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Endovascular Coiling
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Flow Diverters
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country
  • 4.5 Others
    • 4.5.1 Key market trends, growth factors and opportunities
    • 4.5.2 Market size and forecast, by region
    • 4.5.3 Market analysis by country

CHAPTER 5: INTRACRANIAL ANEURYSM MARKET, BY END USER

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Hospitals
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Clinics
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Others
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country

CHAPTER 6: INTRACRANIAL ANEURYSM MARKET, BY REGION

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 North America
    • 6.2.1 Key trends and opportunities
    • 6.2.2 North America Market size and forecast, by Type
    • 6.2.3 North America Market size and forecast, by End User
    • 6.2.4 North America Market size and forecast, by country
      • 6.2.4.1 U.S.
      • 6.2.4.1.1 Market size and forecast, by Type
      • 6.2.4.1.2 Market size and forecast, by End User
      • 6.2.4.2 Canada
      • 6.2.4.2.1 Market size and forecast, by Type
      • 6.2.4.2.2 Market size and forecast, by End User
      • 6.2.4.3 Mexico
      • 6.2.4.3.1 Market size and forecast, by Type
      • 6.2.4.3.2 Market size and forecast, by End User
  • 6.3 Europe
    • 6.3.1 Key trends and opportunities
    • 6.3.2 Europe Market size and forecast, by Type
    • 6.3.3 Europe Market size and forecast, by End User
    • 6.3.4 Europe Market size and forecast, by country
      • 6.3.4.1 Germany
      • 6.3.4.1.1 Market size and forecast, by Type
      • 6.3.4.1.2 Market size and forecast, by End User
      • 6.3.4.2 France
      • 6.3.4.2.1 Market size and forecast, by Type
      • 6.3.4.2.2 Market size and forecast, by End User
      • 6.3.4.3 UK
      • 6.3.4.3.1 Market size and forecast, by Type
      • 6.3.4.3.2 Market size and forecast, by End User
      • 6.3.4.4 Italy
      • 6.3.4.4.1 Market size and forecast, by Type
      • 6.3.4.4.2 Market size and forecast, by End User
      • 6.3.4.5 Spain
      • 6.3.4.5.1 Market size and forecast, by Type
      • 6.3.4.5.2 Market size and forecast, by End User
      • 6.3.4.6 Rest of Europe
      • 6.3.4.6.1 Market size and forecast, by Type
      • 6.3.4.6.2 Market size and forecast, by End User
  • 6.4 Asia-Pacific
    • 6.4.1 Key trends and opportunities
    • 6.4.2 Asia-Pacific Market size and forecast, by Type
    • 6.4.3 Asia-Pacific Market size and forecast, by End User
    • 6.4.4 Asia-Pacific Market size and forecast, by country
      • 6.4.4.1 Japan
      • 6.4.4.1.1 Market size and forecast, by Type
      • 6.4.4.1.2 Market size and forecast, by End User
      • 6.4.4.2 China
      • 6.4.4.2.1 Market size and forecast, by Type
      • 6.4.4.2.2 Market size and forecast, by End User
      • 6.4.4.3 Australia
      • 6.4.4.3.1 Market size and forecast, by Type
      • 6.4.4.3.2 Market size and forecast, by End User
      • 6.4.4.4 India
      • 6.4.4.4.1 Market size and forecast, by Type
      • 6.4.4.4.2 Market size and forecast, by End User
      • 6.4.4.5 South Korea
      • 6.4.4.5.1 Market size and forecast, by Type
      • 6.4.4.5.2 Market size and forecast, by End User
      • 6.4.4.6 Rest of Asia-Pacific
      • 6.4.4.6.1 Market size and forecast, by Type
      • 6.4.4.6.2 Market size and forecast, by End User
  • 6.5 LAMEA
    • 6.5.1 Key trends and opportunities
    • 6.5.2 LAMEA Market size and forecast, by Type
    • 6.5.3 LAMEA Market size and forecast, by End User
    • 6.5.4 LAMEA Market size and forecast, by country
      • 6.5.4.1 Brazil
      • 6.5.4.1.1 Market size and forecast, by Type
      • 6.5.4.1.2 Market size and forecast, by End User
      • 6.5.4.2 Saudi Arabia
      • 6.5.4.2.1 Market size and forecast, by Type
      • 6.5.4.2.2 Market size and forecast, by End User
      • 6.5.4.3 South Africa
      • 6.5.4.3.1 Market size and forecast, by Type
      • 6.5.4.3.2 Market size and forecast, by End User
      • 6.5.4.4 Rest of LAMEA
      • 6.5.4.4.1 Market size and forecast, by Type
      • 6.5.4.4.2 Market size and forecast, by End User

CHAPTER 7: COMPANY LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Key developments

CHAPTER 8: COMPANY PROFILES

  • 8.1 B. Braun
    • 8.1.1 Company overview
    • 8.1.2 Company snapshot
    • 8.1.3 Operating business segments
    • 8.1.4 Product portfolio
    • 8.1.5 Business performance
    • 8.1.6 Key strategic moves and developments
  • 8.2 Delta Surgical
    • 8.2.1 Company overview
    • 8.2.2 Company snapshot
    • 8.2.3 Operating business segments
    • 8.2.4 Product portfolio
    • 8.2.5 Business performance
    • 8.2.6 Key strategic moves and developments
  • 8.3 Evonos GmbH & Co. KG
    • 8.3.1 Company overview
    • 8.3.2 Company snapshot
    • 8.3.3 Operating business segments
    • 8.3.4 Product portfolio
    • 8.3.5 Business performance
    • 8.3.6 Key strategic moves and developments
  • 8.4 Integra Life-science Holding Corporation
    • 8.4.1 Company overview
    • 8.4.2 Company snapshot
    • 8.4.3 Operating business segments
    • 8.4.4 Product portfolio
    • 8.4.5 Business performance
    • 8.4.6 Key strategic moves and developments
  • 8.5 Medtronic PLC
    • 8.5.1 Company overview
    • 8.5.2 Company snapshot
    • 8.5.3 Operating business segments
    • 8.5.4 Product portfolio
    • 8.5.5 Business performance
    • 8.5.6 Key strategic moves and developments
  • 8.6 Microport Scientific Corporation
    • 8.6.1 Company overview
    • 8.6.2 Company snapshot
    • 8.6.3 Operating business segments
    • 8.6.4 Product portfolio
    • 8.6.5 Business performance
    • 8.6.6 Key strategic moves and developments
  • 8.7 Mizuho Medical Incorporation
    • 8.7.1 Company overview
    • 8.7.2 Company snapshot
    • 8.7.3 Operating business segments
    • 8.7.4 Product portfolio
    • 8.7.5 Business performance
    • 8.7.6 Key strategic moves and developments
  • 8.8 Spiegelberg
    • 8.8.1 Company overview
    • 8.8.2 Company snapshot
    • 8.8.3 Operating business segments
    • 8.8.4 Product portfolio
    • 8.8.5 Business performance
    • 8.8.6 Key strategic moves and developments
  • 8.9 Stryker Corporation
    • 8.9.1 Company overview
    • 8.9.2 Company snapshot
    • 8.9.3 Operating business segments
    • 8.9.4 Product portfolio
    • 8.9.5 Business performance
    • 8.9.6 Key strategic moves and developments
  • 8.10 Terumo Global (Microvention)
    • 8.10.1 Company overview
    • 8.10.2 Company snapshot
    • 8.10.3 Operating business segments
    • 8.10.4 Product portfolio
    • 8.10.5 Business performance
    • 8.10.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 2. INTRACRANIAL ANEURYSM MARKET, FOR SURGICAL CLIPPING, BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. INTRACRANIAL ANEURYSM MARKET FOR SURGICAL CLIPPING, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. INTRACRANIAL ANEURYSM MARKET, FOR ENDOVASCULAR COILING, BY REGION, 2021-2031 ($MILLION)
  • TABLE 5. INTRACRANIAL ANEURYSM MARKET FOR ENDOVASCULAR COILING, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 6. INTRACRANIAL ANEURYSM MARKET, FOR FLOW DIVERTERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 7. INTRACRANIAL ANEURYSM MARKET FOR FLOW DIVERTERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 8. INTRACRANIAL ANEURYSM MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 9. INTRACRANIAL ANEURYSM MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 10. GLOBAL INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 11. INTRACRANIAL ANEURYSM MARKET, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 12. INTRACRANIAL ANEURYSM MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 13. INTRACRANIAL ANEURYSM MARKET, FOR CLINICS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 14. INTRACRANIAL ANEURYSM MARKET FOR CLINICS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 15. INTRACRANIAL ANEURYSM MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 16. INTRACRANIAL ANEURYSM MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 17. INTRACRANIAL ANEURYSM MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 18. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 19. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 20. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 21. U.S. INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 22. U.S. INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 23. CANADA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 24. CANADA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 25. MEXICO INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 26. MEXICO INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 27. EUROPE INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 28. EUROPE INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 29. EUROPE INTRACRANIAL ANEURYSM MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 30. GERMANY INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 31. GERMANY INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 32. FRANCE INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 33. FRANCE INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 34. UK INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 35. UK INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 36. ITALY INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 37. ITALY INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 38. SPAIN INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 39. SPAIN INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 40. REST OF EUROPE INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 41. REST OF EUROPE INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 42. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 43. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 44. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 45. JAPAN INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 46. JAPAN INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 47. CHINA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 48. CHINA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 49. AUSTRALIA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 50. AUSTRALIA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 51. INDIA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 52. INDIA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 53. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 54. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 55. REST OF ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 56. REST OF ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 57. LAMEA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 58. LAMEA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 59. LAMEA INTRACRANIAL ANEURYSM MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 60. BRAZIL INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 61. BRAZIL INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 62. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 63. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 64. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 65. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 66. REST OF LAMEA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 67. REST OF LAMEA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 68.B. BRAUN: COMPANY SNAPSHOT
  • TABLE 69.B. BRAUN: OPERATING SEGMENTS
  • TABLE 70.B. BRAUN: PRODUCT PORTFOLIO
  • TABLE 71.B. BRAUN: NET SALES,
  • TABLE 72.B. BRAUN: KEY STRATERGIES
  • TABLE 73.DELTA SURGICAL: COMPANY SNAPSHOT
  • TABLE 74.DELTA SURGICAL: OPERATING SEGMENTS
  • TABLE 75.DELTA SURGICAL: PRODUCT PORTFOLIO
  • TABLE 76.DELTA SURGICAL: NET SALES,
  • TABLE 77.DELTA SURGICAL: KEY STRATERGIES
  • TABLE 78.EVONOS GMBH & CO. KG: COMPANY SNAPSHOT
  • TABLE 79.EVONOS GMBH & CO. KG: OPERATING SEGMENTS
  • TABLE 80.EVONOS GMBH & CO. KG: PRODUCT PORTFOLIO
  • TABLE 81.EVONOS GMBH & CO. KG: NET SALES,
  • TABLE 82.EVONOS GMBH & CO. KG: KEY STRATERGIES
  • TABLE 83.INTEGRA LIFE-SCIENCE HOLDING CORPORATION: COMPANY SNAPSHOT
  • TABLE 84.INTEGRA LIFE-SCIENCE HOLDING CORPORATION: OPERATING SEGMENTS
  • TABLE 85.INTEGRA LIFE-SCIENCE HOLDING CORPORATION: PRODUCT PORTFOLIO
  • TABLE 86.INTEGRA LIFE-SCIENCE HOLDING CORPORATION: NET SALES,
  • TABLE 87.INTEGRA LIFE-SCIENCE HOLDING CORPORATION: KEY STRATERGIES
  • TABLE 88.MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 89.MEDTRONIC PLC: OPERATING SEGMENTS
  • TABLE 90.MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 91.MEDTRONIC PLC: NET SALES,
  • TABLE 92.MEDTRONIC PLC: KEY STRATERGIES
  • TABLE 93.MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 94.MICROPORT SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 95.MICROPORT SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 96.MICROPORT SCIENTIFIC CORPORATION: NET SALES,
  • TABLE 97.MICROPORT SCIENTIFIC CORPORATION: KEY STRATERGIES
  • TABLE 98.MIZUHO MEDICAL INCORPORATION: COMPANY SNAPSHOT
  • TABLE 99.MIZUHO MEDICAL INCORPORATION: OPERATING SEGMENTS
  • TABLE 100.MIZUHO MEDICAL INCORPORATION: PRODUCT PORTFOLIO
  • TABLE 101.MIZUHO MEDICAL INCORPORATION: NET SALES,
  • TABLE 102.MIZUHO MEDICAL INCORPORATION: KEY STRATERGIES
  • TABLE 103.SPIEGELBERG: COMPANY SNAPSHOT
  • TABLE 104.SPIEGELBERG: OPERATING SEGMENTS
  • TABLE 105.SPIEGELBERG: PRODUCT PORTFOLIO
  • TABLE 106.SPIEGELBERG: NET SALES,
  • TABLE 107.SPIEGELBERG: KEY STRATERGIES
  • TABLE 108.STRYKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 109.STRYKER CORPORATION: OPERATING SEGMENTS
  • TABLE 110.STRYKER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 111.STRYKER CORPORATION: NET SALES,
  • TABLE 112.STRYKER CORPORATION: KEY STRATERGIES
  • TABLE 113.TERUMO GLOBAL (MICROVENTION): COMPANY SNAPSHOT
  • TABLE 114.TERUMO GLOBAL (MICROVENTION): OPERATING SEGMENTS
  • TABLE 115.TERUMO GLOBAL (MICROVENTION): PRODUCT PORTFOLIO
  • TABLE 116.TERUMO GLOBAL (MICROVENTION): NET SALES,
  • TABLE 117.TERUMO GLOBAL (MICROVENTION): KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.INTRACRANIAL ANEURYSM MARKET SEGMENTATION
  • FIGURE 2.INTRACRANIAL ANEURYSM MARKET,2021-2031
  • FIGURE 3.INTRACRANIAL ANEURYSM MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.INTRACRANIAL ANEURYSM MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.INTRACRANIAL ANEURYSM MARKET,BY TYPE,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF SURGICAL CLIPPING INTRACRANIAL ANEURYSM MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF ENDOVASCULAR COILING INTRACRANIAL ANEURYSM MARKET,2021-2031(%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF FLOW DIVERTERS INTRACRANIAL ANEURYSM MARKET,2021-2031(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF OTHERS INTRACRANIAL ANEURYSM MARKET,2021-2031(%)
  • FIGURE 17.INTRACRANIAL ANEURYSM MARKET,BY END USER,2021(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF HOSPITALS INTRACRANIAL ANEURYSM MARKET,2021-2031(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF CLINICS INTRACRANIAL ANEURYSM MARKET,2021-2031(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF OTHERS INTRACRANIAL ANEURYSM MARKET,2021-2031(%)
  • FIGURE 21.INTRACRANIAL ANEURYSM MARKET BY REGION,2021
  • FIGURE 22.U.S. INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 23.CANADA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 24.MEXICO INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 25.GERMANY INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 26.FRANCE INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 27.UK INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 28.ITALY INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 29.SPAIN INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 30.REST OF EUROPE INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 31.JAPAN INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 32.CHINA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 33.AUSTRALIA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 34.INDIA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 35.SOUTH KOREA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 36.REST OF ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 37.BRAZIL INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 38.SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 39.SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 40.REST OF LAMEA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 41. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 44.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 45.COMPETITIVE DASHBOARD
  • FIGURE 46.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 47.B. BRAUN.: NET SALES ,($MILLION)
  • FIGURE 48.DELTA SURGICAL.: NET SALES ,($MILLION)
  • FIGURE 49.EVONOS GMBH & CO. KG.: NET SALES ,($MILLION)
  • FIGURE 50.INTEGRA LIFE-SCIENCE HOLDING CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 51.MEDTRONIC PLC.: NET SALES ,($MILLION)
  • FIGURE 52.MICROPORT SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 53.MIZUHO MEDICAL INCORPORATION.: NET SALES ,($MILLION)
  • FIGURE 54.SPIEGELBERG.: NET SALES ,($MILLION)
  • FIGURE 55.STRYKER CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 56.TERUMO GLOBAL (MICROVENTION).: NET SALES ,($MILLION)